© Provided by Xinhua | &This is hope for everyone. We experienced difficult times in our struggle against this disease but now we have an effective
Special to Delta County Independent
Delta County Memorial Hospitalâs (DCMH) Grand Mesa Oncology, Hematology and Infusion Center is excited to welcome its newest physician, Ann Hedderman, M.D. to the team. Hedderman specializes in hematology, the study and treatment of blood diseases, and brings more than 20 years of experience and a background in rural healthcare.
Hedderman is from upstate New York and attended medical school at the University of Iowa Hospital and Clinics before practicing medicine in Indiana. Originally planning to become a thoracic surgeon, Hedderman was drawn to the rapidly expanding field of internal medicine.
âAfter deciding not to go into surgery I did a Hematology rotation [during my medical internship] and am fascinated by blood diseases,â said Hedderman. âItâs exciting to see the new sets of targeted therapies happening for diseases that previously didnât have treatment options. Being in this field of medicine right now is a
Have you beaten COVID-19? The Day is seeking to tell the stories of southeastern Connecticut residents who have tested positive for the disease and survived.
Consortium including ElsaLys Biotech and Novadiscovery awarded €3.35 million by Bpifrance to advance inolimomab in graft-versus-host disease
NOVA awarded €2.4 million
to leverage Jinko, its best-in-class clinical trial simulation platform, to conduct in silico studies for graft-versus-host disease
Research academic teams of the consortium - Institut de Recherche Saint Louis
1
2 -
to receive €0.95 million for their collaborative work with ElsaLys on in vitro and in vivo mechanisms of action of inolimomab
ElsaLys Biotech utilising in silico studies to accelerate the European approval of inolimomab in both adult and paediatric populations with this rare and life-threatening disease
Lyon, France - 19 January 2021: The Silikotac Program consortium, consisting of ElsaLys Biotech, Novadiscovery ( NOVA ) and two expert academic teams from Hôpital St Louis (Paris) and Hôpital Henri Mondor (Paris), has been awarded €3.35 million in non-dilutive funding by Bpifrance to
Covid Tongue: UK professor discovers new oral complications in Covid-19 patients
January 19, 2021
Symptoms include thick patches all over the tongue and mouth ulcers
Researchers and health experts across the world are still trying to wrap their minds around the elusive Covid-19 symptoms.
A leading epidemiologist from King’s College, London, claimed that there is a spike in cases where Covid-19 patients suffer from a rare symptom of oral ulcer.
However, this symptom has not been listed by the WHO (World Health Organization) as one of the Covid-19 symptoms.
Tim Spector, a professor at the King’s College, tweeted: “One in five people with Covid still present with less common symptoms that don’t get on the official PHE (Public Health England) list - such as skin rashes.”